The surgical safety margin after neoadjuvant chemotherapy combined with nimotuzumab leading to tumor regression
{{output}}
Background: To investigate the effect of nimotuzumab (N) combined with nab-paclitaxel, cisplatin, and fluorouracil (APF) neoadjuvant chemotherapy on the surgical margin. ... ...
